Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?

Perrine Janiaud; Lars G. Hemkens; John P A Ioannidis

doi:10.1016/j.cjca.2021.05.009

Related publications

Article2021

Lessons Learned from COVID-19 Trials – Should We Be Doing Clinical Trials Differently?

Perrine Janiaud, Lars G. Hemkens, John P A Ioannidis

Article2024

Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic

Niloufar Yazdanpanah, Constantine Sedikides, Hans D. Ochs, Carlos A. Camargo, Gary L. Darmstadt, Artemi Cerdà, Valentina Cauda, Godefridus J. Peters, Frank W. Sellke, Nathan D. Wong, Elisabetta Comini, A. Ruiz-Jimeno, Vivette Glover, Nikos Hatziargyriou, Christian E. Vincenot, Stéphane Bordas, Idupulapati M. Rao, Hassan Abolhassani, Gevork B. Gharehpetian, Ralf Weiskirchen, Manoj Gupta, Shyam Singh Chandel, Bolajoko O. Olusanya, Bruce D. Cheson, Alessio Pomponio, Michael Tänzer, Paul S. Myles, Wen‐Xiu Ma, Federico Bella, Saeid Ghavami, S. Moein Moghimi, Domenico Praticò, Alfredo Martínez Hernandez, María Martínez‐Urbistondo, Diego Martínez‐Urbistondo, Seyed‐Mohammad Fereshtehnejad, Imran Ali, Shinya Kimura, A. Wallace Hayes, Wenju Cai, K.J. Chua, Sabu Thomas, Kazem Rahimi, Armin Sorooshian, Michael Schreiber, Koichi Kato, John H. T. Luong, Stefano Pluchino, Andrés M. Lozano, John F. Seymour, Kenneth S. Kosik, Stefan G. Hofmann, Roger S. McIntyre, Matjaž Perc, Alexander Leemans, Robyn S. Klein, Shuji Ogino, Christopher Wlezien, George Perry, Juan J. Nieto, Lisa A. Levin, Daniel J. Klionsky, Bahram Mobasher, T. Dorigo, Nima Rezaei

Article2020

Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?

Discussion(0)

Related publications

Lessons Learned from COVID-19 Trials – Should We Be Doing Clinical Trials Differently?

Global Challenges After a Global Challenge: Lessons Learned from the COVID-19 Pandemic

Lessons learned from COVID-19 on potentially pathogenic soil microorganisms

Ten things we learned about COVID-19

Therapeutic strategies for COVID-19: progress and lessons learned